IPP Bureau
Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat
By IPP Bureau - December 20, 2024
This facility marks a significant milestone in transforming the global food industr
Cipla launches India's first inhalable insulin ‘Afrezza’
By IPP Bureau - December 19, 2024
Afrezza, developed by MannKind Corporation in the USA, offers a needle-free, rapid-acting insulin option for diabetes management
Caplin Steriles gets USFDA approval for Difluprednate Ophthalmic emulsion
By IPP Bureau - December 17, 2024
Difluprednate Ophthalmic Emulsion, 0.05% is a topical corticosteroid that is indicated in the treatment of inflammation and pain associated with ocular surgery
Zaynich enables US cancer patient undergo successful liver transplant and resume chemotherapy
By IPP Bureau - December 17, 2024
In the US, the compassionate use approvals are provided by FDA in the form of individual patient-specific expanded-access IND
Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL
By IPP Bureau - December 17, 2024
According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
Merck to discontinue KeyVibe and Keyform clinical trials
By IPP Bureau - December 17, 2024
Merck has also decided to end the favezelimab clinical development program
SPARC signs LoI with UCSF and Tiller Therapeutics for pre-clinical oncology asset and associated IP
By IPP Bureau - December 17, 2024
SPARC to receive 55% equity in Tiller Therapeutics
Granules India FDA approval for ADHD treatment
By IPP Bureau - December 17, 2024
Supriya Lifescience inaugurates Rs. 125 crore new API production block in Maharashtra
By IPP Bureau - December 17, 2024
The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL
Merck to acquire HUB Organoids to advance cell culture portfolio
By IPP Bureau - December 17, 2024
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Bayer announces positive topline resukts for Aflibercept 8 mg in phase III study
By IPP Bureau - December 17, 2024
Demonstrates vision gains with extended treatment intervals in retinal vein occlusion
Rusan Pharma achieves GMP approvals from TGA (Australia) and ANVISA (Brazil) for its manufacturing facility in Kandla SEZ
By IPP Bureau - December 17, 2024
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Merck announces FDA acceptance of biologics license application for Clesrovimab
By IPP Bureau - December 17, 2024
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Kiran Mazumdar-Shaw honored by ISQ with ‘Jamsetji Tata Award’ for pioneering biosciences movement
By IPP Bureau - December 16, 2024
Kiran Mazumdar-Shaw received the award from Janak Kumar Mehta, President of ISQ and Chairman & Managing Director, TQM International
Jitendra Singh releases landmark RSSDI study ' Indian Prevention of Diabetes Study (IPDS) on Yoga and Diabetes Prevention'
By IPP Bureau - December 16, 2024
A 40 minute daily Yoga routine, incorporating select asanas and pranayama, along with standard lifestyle interventions, can reduce the risk of developing diabetes by approximately 40%
